BioSpace News Archive

Dyne Therapeutics, Inc today announced that management is scheduled to present at the following investor conferences in November.

QuantuMDx Group Limited and A.Menarini Diagnostics S.r.I., are pleased to announce an exclusive distribution agreement for QuantuMDx’s Q-POC™ platform in the UK and France.

Inspire Medical Systems, Inc. announced that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY.

Revolo Biotherapeutics announced that the U.S. Patent and Trademark Office issued US Patent No. 11,479,585 on October 25, 2022, which covers IRL201104 and related peptides in methods related to the acute treatment of relapsing remitting conditions.

Cocrystal Pharma, Inc. announces that management will participate in two upcoming investor conferences as follows.

Evotec SE presents at its Capital Markets Day an update on how the Company is taking meaningful steps to transform biologics manufacturing to enable global access.

Editas Medicine, Inc., a clinical stage genome editing company, reported business highlights and financial results for the third quarter of 2022.

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended September 30, 2022.

G1 Therapeutics, Inc., a commercial-stage oncology company, described safety data from the first 18 patients enrolled in its ongoing Phase 2, single arm study of trilaciclib administered prior to the antibody-drug conjugate, sacituzumab govitecan-hziy in patients with unresectable locally advanced or metastatic triple-negative breast cancer.

Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, provided a corporate update and reported financial results for the third quarter of 2022.